Recurrent C3 glomerulopathy after kidney transplantation

S Obata, PASV de Castro, LV Riella, P Cravedi - Transplantation Reviews, 2024 - Elsevier
The complement system is part of innate immunity and is pivotal in protecting the body
against pathogens and maintaining host homeostasis. Activation of the complement system …

[HTML][HTML] The 14th International Podocyte conference 2023: From podocyte biology to glomerular medicine

S Koehler, F Hengel, B Dumoulin, L Damashek… - Kidney International, 2024 - Elsevier
Abstract The 14th International Podocyte Conference took place in Philadelphia, USA, from
May 23rd to 26th, 2023. It commenced with an early-career researchers' meeting on May …

[HTML][HTML] The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

M Vivarelli, J Barratt, LH Beck Jr, F Fakhouri, DP Gale… - Kidney International, 2024 - Elsevier
Uncontrolled complement activation can cause or contribute to glomerular injury in multiple
kidney diseases. While complement activation plays a causal role in atypical hemolytic …

[HTML][HTML] Clinical relevance of anti-C3 and anti-C4 autoantibodies in lupus nephritis

V Vasilev, MR Artero, M Petkova, G Mihaylova… - Kidney International …, 2024 - Elsevier
Introduction Complement system overactivation is pivotal in lupus nephritis (LN)
pathophysiology. Considering that anti-C3 autoantibodies play a significant role in LN …

[HTML][HTML] Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 Glomerulopathy

JJ Hauer, Y Zhang, R Goodfellow, A Taylor… - Kidney international …, 2024 - Elsevier
Introduction C3 glomerulopathy (C3G) is an ultrarare renal disease characterized by
deposition of complement component C3 in the glomerular basement membrane (GBM) …

Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy

MS Meuleman, F Petitprez, MC Pickering… - Journal of the …, 2024 - journals.lww.com
Background: C3 glomerulopathy is a rare disease resulting from an overactivation of the
complement alternative pathway. Although there is also evidence of terminal pathway …

[HTML][HTML] A cell-based assay to measure the activity of the complement convertases

M Stasiłojć, G Stasiłojć, A Kuźniewska… - Kidney International …, 2024 - Elsevier
Introduction The complement system serves as a crucial defense mechanism against
invading pathogens; however, dysregulation of this system can result in harmful …

[HTML][HTML] Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 …

M van Schaik, APJ de Vries, FJ Bemelman… - Kidney International …, 2024 - Elsevier
Complement factor 3 glomerulopathy (C3G) is caused by dysregulation of the alternative
complement pathway (AP), resulting in either dense deposit disease or complement factor 3 …

Complément dans les glomérulopathies à dépôts de C3: exploration et conséquences thérapeutiques

A Couasnard, MA Dragon-Durey, C El Sissy - Revue Francophone des …, 2024 - Elsevier
Résumé Les glomérulopathies à C3 sont des pathologies chroniques rares dont le
diagnostic repose sur la présence de dépôts glomérulaires prédominants de C3. Elles …

Pathogenese der C3-Glomerulopathie

B Hohenstein - Nieren-und Hochdruckkrankheiten, 2024 - search.proquest.com
Komplementvermittelte Glomerulonephritiden (GN) werden seit dem Erscheinen der letzten
KDIGO-Leitlinie zu glomerulären Erkrankungen wieder primär in die Gruppe der GN mit …